Lynx Dx

Lynx Dx

Biotechnology Research

Ann Arbor, Michigan 1,636 followers

Our mission is to improve patient care through science-based, best-in-class technology.

About us

MyProstateScore 2.0 is a personalized, comprehensive, data-driven prostate cancer screening solution designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7). The algorithm is specifically optimized for unrivaled accuracy for both previously negative biopsy and biopsy naïve patients.

Website
https://www.lynxdx.com/
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Ann Arbor, Michigan
Type
Privately Held
Founded
2015
Specialties
qPCR, Prostate Cancer Diagnostics, and COVID19 Testing

Locations

Employees at Lynx Dx

Updates

Similar pages

Browse jobs

Funding

Lynx Dx 1 total round

Last Round

Debt financing

US$ 925.0K

See more info on crunchbase